Use este identificador para citar ou linkar para este item: http://repo.saocamilo-sp.br:8080/jspui/handle/123456789/1988
Título: Cutaneous manifestations of COVID-19 patients in a Hospital in São Paulo, Brazil, and global literature review
Autor(es): Cestari, Silmara da Costa Pereira
Cestari, Marcela da Costa Pereira
Marques, Gabriela Franco
Lirio, Ivana
Tovo, Reinaldo
Labriola, Ilana Cruz Silva
Palavras-chave: Covid -19
Manifestações cutâneas
SARS-CoV-2
Pandemias
Data do documento: 2023
Editor: Sociedade Brasileira de Dermatologia
Citação: Cestari, Silmara da Costa Pereira, et al. “Cutaneous manifestations of COVID-19 patients in a Hospital in São Paulo, Brazil, and global literature review”. Anais Brasileiros de Dermatologia, vol. 98, no 4, julho de 2023, p. 466–71. DOI.org (Crossref), https://doi.org/10.1016/j.abd.2022.09.007.
Resumo: Background: Since the beginning of the COVID-19 pandemic, a myriad of cutaneous manifesta tions have been described in association with this viral infection. However, in Latin America, this kind of data is still scarce. Objective: In this sense, the goal of this study was to describe the dermatological findings observed during SARS-CoV-2 infection, in a Brazilian Hospital. Methods: This is a cross-sectional, retrospective and descriptive study of 50 cases of new onset dermatologic symptoms in patients with COVID-19, treated at Hospital Sírio-Libanês, from February to June 2020. Results: The patients (n = 50) were classified into 6 groups, according to the elementary lesions and the statistical analysis was performed. The most common cutaneous lesions were maculopapular eruptions (44%), necrosis, purpura, and livedo (32%), urticarial lesions (12%), pseudochilblains (4%) and papular-vesicular eruption (4%). In 46% of the patients the cutaneous lesions occurred in association with other symptoms, such as pruritus (38%), pain and burning sensation (8%). Lower limbs were affected in 44% of the cases, followed by the trunk (38%), upper limbs (24%) and face (14%). Cutaneous lesions were mostly found after other COVID-19 systemic symptoms, with a mean period between the viral syndrome and cutaneous signs of 5 days (SD = 6.1 days). Study limitations: It is a small sample, in a single-center study, with patients exclusively from a private Hospitals. Conclusions: Patients in Brazil have the same proportion of lesions as revealed in other studies in Europa. The compiled data is essential for a better understanding of cutaneous manifestations deemed secondary to COVID.
URI: http://repo.saocamilo-sp.br:8080/jspui/handle/123456789/1988
ISSN: 0365-0596
Aparece nas coleções:Artigos de Periódicos

Arquivos associados a este item:
Não existem arquivos associados a este item.


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.